2m 2m 2m 2m 2m 2m 2m
ERNEXA THERAPE (ERNA)
NASDAQ
$1.85-$0.08 (-4.40%)
Price as of Nov 12, 2026 8:01 AM EST- $2.3MMarket Cap
- -95.20%1-Year Change
- BiotechnologyIndustry
ERNEXA THERAPE (ERNA)
$1.85-$0.08 (-4.40%)
ERNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.93 | ||
Change | -$0.08 (-3.98%) | ||
Open | $2.05 | ||
High | $2.05 | ||
Low | $1.90 | ||
Previous Close | $2.01 | ||
Volume | 9,815 | ||
30-Day Average Volume | 16,099 | ||
1-Week Change | -3.02% | ||
1-Month Change | -19.58% | ||
1-Year Change | -95.20% | ||
3-Year Change | -99.56% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.7M | ||
Total Assets | $7.1M | ||
Market Cap | $2.3M | ||
Enterprise Value | -$2.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$2.9M | ||
EBITDA | -$2.9M | ||
Net Working Capital | $4.1M | ||
EPS | -$1.89 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 05/04/2026 | ||
Earnings & Revenue